Emprumapimod (PF-07265803) is a potent, orally active and selective inhibitor of p38alpha MAPK directly inhibits LPS-induced IL-6 production from RPMI-8226 cell (IC50=100 pM). Emprumapimod can be used for the research of dilated cardiomyopathy and acute inflammatory pain.
Molecular Weight:
473.52
Purity:
99.0%
CAS Number:
[765914-60-1]
Formula:
C24H29F2N5O3
Target:
p38 MAPK
* VAT and and shipping costs not included. Errors and price changes excepted
